Javad Heshmati, Kerri-Anne Mullen, Kathryn L Walker, Hassan Mir
{"title":"Vaping is associated with increased length of stay among cardiac inpatients.","authors":"Javad Heshmati, Kerri-Anne Mullen, Kathryn L Walker, Hassan Mir","doi":"10.18332/tid/207800","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The rapid increase in e-cigarette use, especially among youth, raises significant health concerns. Understanding their impact on high-risk populations, such as those with cardiovascular disease, is crucial for improving patient outcomes and reducing healthcare utilization. The aim of this study is to assess the impact of e-cigarette use on hospital length of stay (LOS) in patients with cardiovascular disease.</p><p><strong>Methods: </strong>This cross-sectional survey was conducted at the University of Ottawa Heart Institute (November 2019-May 2020) among consecutive cardiology inpatients. Eligible participants were those admitted to the cardiac unit, fluent in French or English, and without cognitive or hearing impairments. The primary outcome is length of hospital stay. Data analysis included descriptive statistics and adjusted linear regression to explore e-cigarette use and hospital stay length, with significance set at p<0.05.</p><p><strong>Results: </strong>Of 1616 cardiac patients, 1089 (73.0%) completed the survey. E-cigarette ever users were 10.4% (4.9% former, 5.5% current). Mean LOS was 11.03 days, longer for ever-users (13.1 days) than never-users (10.8 days). Ever users had a significantly longer LOS by 2.45 days (p=0.040), and current users by 3.24 days (p=0.039).</p><p><strong>Conclusions: </strong>E-cigarette use is associated with longer hospital stays among cardiac patients, even after adjusting for confounders. This underscores the potential harmful effects of vaping on cardiac recovery. Further research is needed to explore these associations and their implications for healthcare utilization.</p>","PeriodicalId":23202,"journal":{"name":"Tobacco Induced Diseases","volume":"23 ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309841/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Induced Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18332/tid/207800","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The rapid increase in e-cigarette use, especially among youth, raises significant health concerns. Understanding their impact on high-risk populations, such as those with cardiovascular disease, is crucial for improving patient outcomes and reducing healthcare utilization. The aim of this study is to assess the impact of e-cigarette use on hospital length of stay (LOS) in patients with cardiovascular disease.
Methods: This cross-sectional survey was conducted at the University of Ottawa Heart Institute (November 2019-May 2020) among consecutive cardiology inpatients. Eligible participants were those admitted to the cardiac unit, fluent in French or English, and without cognitive or hearing impairments. The primary outcome is length of hospital stay. Data analysis included descriptive statistics and adjusted linear regression to explore e-cigarette use and hospital stay length, with significance set at p<0.05.
Results: Of 1616 cardiac patients, 1089 (73.0%) completed the survey. E-cigarette ever users were 10.4% (4.9% former, 5.5% current). Mean LOS was 11.03 days, longer for ever-users (13.1 days) than never-users (10.8 days). Ever users had a significantly longer LOS by 2.45 days (p=0.040), and current users by 3.24 days (p=0.039).
Conclusions: E-cigarette use is associated with longer hospital stays among cardiac patients, even after adjusting for confounders. This underscores the potential harmful effects of vaping on cardiac recovery. Further research is needed to explore these associations and their implications for healthcare utilization.
期刊介绍：
Tobacco Induced Diseases encompasses all aspects of research related to the prevention and control of tobacco use at a global level. Preventing diseases attributable to tobacco is only one aspect of the journal, whose overall scope is to provide a forum for the publication of research articles that can contribute to reducing the burden of tobacco induced diseases globally. To address this epidemic we believe that there must be an avenue for the publication of research/policy activities on tobacco control initiatives that may be very important at a regional and national level. This approach provides a very important "hands on" service to the tobacco control community at a global scale - as common problems have common solutions. Hence, we see ourselves as "connectors" within this global community.
The journal hence encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through health professionals to basic biomedical and clinical scientists.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
